Autologous bone marrow-derived mesenchymal stem cells (University of Jordan)

N/A

Report date: 2023/01/12 15:29:59

Base Information

Drug NameAutologous bone marrow-derived mesenchymal stem cells (University of Jordan)

Drug Alias Name自体骨髓间充质干细胞（约旦大学）autologous BM-MSCs

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derivedCell and gene therapy > Cell therapy > Donor > Autologous

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsLow Back PainMultiple SclerosisIntervertebral Disc Degeneration

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItalyJordan

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesThe University Of Jordan

China Registration ClassN/A

Develop Information

Active CompaniesCampus Bio-Medico University

Inactive CompaniesThe University Of Jordan

Active IndicationsLow Back PainIntervertebral Disc Degeneration

Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A